| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.34 | 0.08 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.27 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.26 | 0.002 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.002 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.23 | 0.3 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.23 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.003 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.004 |